Physician profile
Erin Wolf
NPI 1780794412
$1,472.29
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $250 · 2023: $832 · 2024: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $219.84 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $147.78 | 2022-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $113.40 | 2022-2024 | Mounjaro, Emgality, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.40 | 2022-2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $91.59 | 2022-2024 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $90.21 | 2022-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.47 | 2023-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $77.60 | 2022-2023 | |
| Inspire Medical Systems, INC. | $65.01 | 2023-2024 | Inspire |
| Otsuka America Pharmaceutical, INC. | $60.20 | 2023-2024 | Rexulti |
| Medtronic, INC. | $49.16 | 2023-2024 | Intellis Adaptivestim |
| Abbvie INC. | $46.35 | 2023 | |
| Exact Sciences Corporation | $44.37 | 2023-2024 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $40.71 | 2023 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $35.13 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.48 | 2024 | |
| Antares Pharma, INC. | $27.23 | 2023 | Nocdurna, Xyosted, Tlando |
| Alkermes, INC. | $21.84 | 2022 | |
| Tris Pharma INC | $19.71 | 2023 | Dyanavel Xr |
| Dexcom, INC. | $18.32 | 2023 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $17.80 | 2022 | |
| Horizon Therapeutics Plc | $17.76 | 2022 | |
| Vivus LLC | $17.31 | 2022 | |
| Radius Health, INC. | $17.10 | 2023 | |
| Daiichi Sankyo INC. | $13.86 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.